Medication info
Nesina Tablets 12.5 mg (Alogliptin Benzoate)

Nesina Tablets 12.5 mg (Alogliptin Benzoate)

Prescription medicationTablet
Ingredient · strength
Alogliptin Benzoate›17mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
Pale yellow, oval, film-coated tablet with a score line on both sides
Packaging
28 tablets/Alu-Alu[(14×2ea)], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202303030 · Approved 2023.10.30 · Insurance code 693903780

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this drug is 25mg once daily. It may be taken with or without food. Patients with renal impairment: - Mild renal impairment (creatinine clearance ≥50mL/min): No dosage adjustment is required. - Moderate renal impairment (creatinine clearance 30≤ ~ <50mL/min): Administer 12.5mg of this drug once daily. - Severe renal impairment (creatinine clearance <30mL/min) or end-stage renal disease (ESRD) requiring hemodialysis: Administer 6.25mg of this drug once daily. This drug may be administered regardless of the timing of dialysis. As dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this drug and periodically thereafter.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It works as an adjunct to diet and exercise and can be used alone or in combination with other medications. This helps to manage blood sugar levels steadily and supports a healthy lifestyle.

Dosage and Administration

Adult dosage

The recommended dose of this drug is 25mg once daily. It may be taken with or without food. Patients with renal impairment: - Mild renal impairment (creatinine clearance ≥50mL/min): No dosage adjustment is required. - Moderate renal impairment (creatinine clearance 30≤ ~ <50mL/min): Administer 12.5mg of this drug once daily. - Severe renal impairment (creatinine clearance <30mL/min) or end-stage renal disease (ESRD) requiring hemodialysis: Administer 6.25mg of this drug once daily. This drug may be administered regardless of the timing of dialysis. As dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this drug and periodically thereafter.

Precautions

This medication should not be used in patients with an allergic reaction to the active ingredient or other components. It is not appropriate for patients with diabetic ketoacidosis, diabetic coma, or type 1 diabetes, and insulin treatment may be necessary if rapid control of blood sugar is required. In patients with severe infections, before and after surgery, or with severe trauma, insulin injections may be needed, making this medication unsuitable. Caution is warranted in patients with moderate to severe renal impairment or those on dialysis for end-stage renal disease. It is not recommended for patients with heart failure classified as NYHA functional class III-IV. Caution is advised in patients taking sulfonylureas, those with pituitary disorders, adrenal insufficiency, malnourished individuals, those with irregular meal intake, individuals who have engaged in strenuous physical activity, and those consuming excessive alcohol. This medication may cause side effects such as nasopharyngitis, headache, upper respiratory tract infections, and rarely pancreatitis or hypersensitivity. Symptoms of hypoglycemia may occur, requiring dosage adjustments if used in combination with insulin or other hypoglycemic agents. If symptoms of acute pancreatitis are suspected, the medication should be discontinued immediately and medical advice should be sought. In case of severe hypersensitivity reactions, use must be discontinued immediately, and appropriate treatment should be received; special caution is needed in patients with a history of angioedema due to other similar medications. If symptoms of liver dysfunction appear, testing should be performed immediately, and the medication should be discontinued if necessary. Patients experiencing severe arthralgia or blistering skin disorders while on this medication should inform their healthcare provider immediately. Pregnant or breastfeeding women are advised against the use of this medication, and safety in pediatric patients has not been established. Elderly patients may require dosage adjustments due to common renal function decline. Caution should be exercised in patients with severe hepatic impairment. In cases of overdose, appropriate treatment and monitoring should be provided under medical guidance, as drug removal via blood dialysis is limited. This medication should be stored out of reach of children and kept in its original container to prevent quality deterioration or misuse.

Side effects

  • Pharyngitis
  • headache
  • upper respiratory infection
  • pancreatitis
  • hypersensitivity reaction
  • hypoglycemia
  • anaphylaxis
  • angioedema
  • rash
  • urticaria
Show 191 more
  • Stevens-Johnson syndrome
  • erythema multiforme
  • elevated liver enzyme levels
  • fulminant hepatic failure
  • severe and disabling arthralgia
  • acute pancreatitis
  • intestinal obstruction
  • interstitial nephritis
  • tendinitis
  • fracture
  • costochondritis
  • leg fracture
  • upper limb fracture
  • spinal fracture
  • rhabdomyolysis
  • diarrhea
  • gastric ulcer
  • exacerbation of gastritis
  • hemorrhagic gastric ulcer
  • appendicitis
  • hyperglycemia
  • worsening of diabetes
  • acidosis
  • abscess
  • infection
  • wound deficit
  • thyroid carcinoma
  • lung cancer
  • chest discomfort
  • low back pain
  • generalized edema
  • systemic weakness
  • dyspnea
  • exacerbation of asthma
  • worsening of pneumonia
  • respiratory arrest
  • acute kidney failure
  • kidney stones
  • abnormal kidney function
  • cirrhosis
  • cholelithiasis
  • myocardial infarction
  • angina pectoris
  • anorexia
  • cerebral infarction
  • transient ischemic attack
  • laceration
  • exacerbation of atrial fibrillation
  • speech disorder
  • stomatitis
  • abdominal pain
  • gastroesophageal reflux disease
  • esophagitis
  • gastrointestinal disorders
  • atrophic gastritis
  • non-food-related epigastric pain
  • enteritis
  • heartburn
  • abdominal discomfort
  • abdominal distension
  • upper abdominal pain
  • peptic ulcer
  • gastric pain
  • gastritis
  • dry mouth
  • periodontitis
  • toothache
  • belching
  • anal fissure
  • blood in stool
  • dark stool
  • constipation
  • nausea
  • vomiting
  • cough
  • increased sputum
  • bronchospasm
  • dry cough
  • chronic obstructive pulmonary disease
  • throat irritation
  • sinusitis
  • sore throat
  • tonsillitis
  • sputum disorders
  • bronchitis
  • runny nose
  • rhinitis
  • hemoptysis
  • vitamin D deficiency
  • increased triglycerides
  • increased CPK
  • hypertriglyceridemia
  • hyperkalemia
  • dry eye syndrome
  • gout
  • increased blood glucose levels
  • hyperlipidemia
  • diabetes complications
  • chest pain
  • back pain
  • fatigue
  • pelvic pain
  • leg pain
  • fever
  • edema
  • leg edema
  • worsening back pain
  • weakness
  • sacroiliac pain
  • pain
  • arm edema
  • exacerbation of chest pain
  • skin tingling
  • sensory abnormalities
  • thigh sensory abnormalities
  • fecal incontinence
  • tremor
  • numbness
  • neuropathic pain
  • spinal stenosis
  • hemiplegia
  • skin sensory abnormalities
  • dizziness
  • lightheadedness
  • vertigo
  • ligament injury
  • joint pain
  • fibromyalgia
  • muscle cramps
  • myalgia
  • leg weakness
  • malaise
  • trigger finger
  • plantar fasciitis
  • tendon rupture
  • osteoarthritis
  • pruritus
  • contact dermatitis
  • keratosis
  • sclerosis
  • increased sweating
  • nail disorders
  • otitis externa
  • erythema multiforme
  • rosacea
  • furunculosis
  • seborrheic dermatitis
  • conjunctivitis
  • glaucoma
  • macular degeneration
  • cataracts
  • keratitis
  • retinopathy
  • retinal disorders
  • bladder inflammation
  • exacerbation of cystitis
  • frequent urination
  • neurogenic bladder
  • kidney cyst
  • urethritis
  • hematuria
  • increased serum creatinine
  • unspecified abnormal liver function test
  • cholangitis
  • fatty liver
  • shingles
  • herpes labialis
  • herpes virus infection
  • benign prostatic hyperplasia
  • benign prostatic hyperplasia
  • depression
  • hypersensitivity
  • erectile dysfunction
  • insomnia
  • sleep disorder
  • tinnitus
  • acute hearing loss
  • Ménière's disease
  • unspecified ear disease
  • coronary artery occlusion
  • worsening angina pectoris
  • cataract extraction
  • laceration
  • bradycardia
  • palpitations
  • orthostatic hypotension
  • hypotension
  • atherosclerosis
  • hypothyroidism
  • nodular goiter
  • hypertension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect from air and moisture. It is recommended to store it at room temperature, between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow, oval, film-coated tablet with a score line on both sides

Package unit

28 tablets/Alu-Alu[(14×2ea)], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.